What is the management approach for Simpson-Golabi-Behmel syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Simpson-Golabi-Behmel Syndrome

The management of Simpson-Golabi-Behmel syndrome (SGBS) requires a multidisciplinary approach with regular surveillance for associated complications, particularly tumor screening for Wilms tumor and hepatoblastoma, along with supportive care for various organ system manifestations.

Clinical Features and Diagnosis

SGBS is an X-linked overgrowth syndrome characterized by:

  • Pre- and postnatal macrosomia (overgrowth)

  • Distinctive craniofacial features:

    • Macrocephaly
    • Coarse facial features
    • Macrostomia (large mouth)
    • Macroglossia (large tongue)
    • Hypertelorism (widely spaced eyes)
  • Other common features:

    • Supernumerary nipples
    • Diastasis recti/umbilical hernia
    • Congenital heart defects
    • Skeletal anomalies
    • Hand anomalies (large hands, polydactyly)
    • Mild to severe intellectual disability (though many have normal intelligence)
    • Organomegaly

Genetic Basis

  • SGBS is caused by mutations or deletions in the glypican genes:
    • GPC3 (most common) or GPC4 on chromosome Xq26 1
    • These genes encode extracellular proteoglycans that interact with insulin-like growth factor (IGF2) 1
  • X-linked inheritance pattern (primarily affects males, though females can be affected) 2

Management Approach

1. Multidisciplinary Team

A coordinated team should include:

  • Pediatrician/Primary care physician
  • Medical geneticist
  • Oncologist
  • Nephrologist
  • Cardiologist
  • Neurologist
  • Orthopedic specialist
  • Developmental specialist

2. Tumor Surveillance

SGBS patients have increased risk for embryonal tumors, particularly:

  • Wilms tumor and nephroblastomatosis 3, 2
  • Hepatoblastoma and other liver tumors 3
  • Neuroblastoma 3

Recommended screening protocol:

  • Abdominal ultrasound every 3-4 months until at least age 7 years 3
  • This should include thorough examination of both kidneys and liver
  • Consider serum alpha-fetoprotein (AFP) monitoring for hepatoblastoma risk

3. Organ System Management

Cardiovascular System

  • Echocardiogram at diagnosis
  • Cardiology follow-up for congenital heart defects

Renal System

  • Regular renal function assessment
  • Ultrasound monitoring for structural abnormalities
  • Management of renal dysplasia if present

Neurological System

  • Developmental assessment
  • Early intervention for developmental delays
  • Neuroimaging if neurological symptoms present

Skeletal System

  • Orthopedic evaluation for skeletal anomalies
  • Management of vertebral fusion, scoliosis, or hip dislocation if present

Gastrointestinal System

  • Assessment and management of GI anomalies
  • Feeding support if needed

4. Growth and Development

  • Regular growth monitoring using appropriate growth charts
  • Developmental assessment and early intervention services
  • Educational support for those with intellectual disability

5. Genetic Counseling

  • Family genetic counseling
  • Carrier testing for female relatives
  • Prenatal diagnosis options for future pregnancies

Prognosis

The clinical spectrum of SGBS is broad:

  • Mild forms with normal intelligence and good prognosis
  • Severe forms with multiple congenital anomalies and early mortality
  • Infantile lethal variant associated with hydrops fetalis 4

Special Considerations

  • Female carriers: While SGBS is X-linked, affected females have been reported and may require similar management approaches 2
  • Cancer risk: Ongoing surveillance is critical as tumor development can occur throughout childhood
  • Severity spectrum: Management should be tailored to the severity of presentation, which can range from mild to lethal 4, 5

Follow-up Care

  • Regular follow-up with multidisciplinary team
  • Ongoing developmental assessment
  • Continued tumor surveillance throughout childhood
  • Transition planning to adult care for adolescents

The management of SGBS requires vigilant monitoring for complications, particularly tumors, while providing supportive care for the various manifestations of this complex syndrome.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.